Testing effectiveness (Phase 2)Study completedNCT05021484What this trial is testingFelzartamab in Late Antibody-Mediated RejectionWho this might be right forAntibody-mediated Rejection Farsad Eskandary 22
Not applicableActive Not RecruitingNCT06481280What this trial is testingEvaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.Who this might be right forCow's Milk Allergy United Pharmaceuticals 70
Not applicableActive Not RecruitingNCT07316829What this trial is testingTRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiSWho this might be right forGraft RejectionKidney TransplantationLung Transplantation+6 more Fondazione IRCCS Policlinico San Matteo di Pavia 30
Testing effectiveness (Phase 2)Looking for participantsNCT06285539What this trial is testingDrug Rediscovery for Rare Immune Mediated Inflammatory DiseasesWho this might be right forBehcet's DiseaseIdiopathic Inflammatory MyopathiesIgG4-related Disease UMC Utrecht 60
Testing effectiveness (Phase 2)Study completedNCT00670774What this trial is testingDosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney TransplantWho this might be right forKidney Transplant Mark Stegall 31
Testing effectiveness (Phase 2)Ended earlyNCT02854059What this trial is testingIdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) PatientsWho this might be right forPurpura, Thrombotic Thrombocytopenic Hansa Biopharma AB 2
Early research (Phase 1)Looking for participantsNCT06948097What this trial is testingSyk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific AntibodiesWho this might be right forLung Transplantation National Heart, Lung, and Blood Institute (NHLBI) 30
Not applicableStudy completedNCT05452317What this trial is testingAssess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated RejectionWho this might be right forAntibody-mediated Rejection in Kidney Transplant CSL Behring 52
Not applicableUnknownNCT04414735What this trial is testingImpact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Fundacion Clinic per a la Recerca Biomédica 30
Not applicableActive Not RecruitingNCT05184426What this trial is testingMuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)Who this might be right forTransplant FailureHeart Transplant RejectionAntibody-mediated Rejection Juan Francisco Delgado Jimenez 90
Early research (Phase 1)Looking for participantsNCT07305116What this trial is testingCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more The Children's Hospital of Zhejiang University School of Medicine 15
Not applicableActive Not RecruitingNCT04411147What this trial is testingA Longitudinal Study of COVID-19 Sequelae and ImmunityWho this might be right forCOVID-19 National Institute of Allergy and Infectious Diseases (NIAID) 583
Early research (Phase 1)Study completedNCT00450827What this trial is testingIodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory NeuroblastomaWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center 25
Not applicableUnknownNCT00799019What this trial is testingA Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneous Exposure in ThailandWho this might be right forErythropoietin Chulalongkorn University 6,500
Not applicableEnded earlyNCT04711850What this trial is testingAn Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMRWho this might be right forKidney Transplant Rejection Hansa Biopharma AB 18
Testing effectiveness (Phase 2)WithdrawnNCT04956276What this trial is testingSubcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic AnemiaWho this might be right forWarm Autoimmune Hemolytic Anemia Alexion Pharmaceuticals, Inc.
Post-approval studies (Phase 4)WithdrawnNCT02130817What this trial is testingBelatacept in Kidney Transplantation of Moderately Sensitized PatientsWho this might be right forEnd Stage Renal DiseaseAntibody Mediated Rejection University of Wisconsin, Madison
Large-scale testing (Phase 3)Active Not RecruitingNCT05832034What this trial is testingAdd-on Intravenous Immunoglobulins in Early MyositisWho this might be right forInflammatory Myopathy, IdiopathicDermatomyositisAntisynthetase Syndrome+3 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 44
Testing effectiveness (Phase 2)Study completedNCT00050245What this trial is testingRituximab to Treat Neuropathy With Anti-MAG AntibodiesWho this might be right forPolyneuropathies National Institute of Neurological Disorders and Stroke (NINDS) 30
Not applicableEnded earlyNCT02120482What this trial is testingCombined Apheresis for ABO-incompatible Transplantation - a Pilot StudyWho this might be right forDecreased Immunologic ActivityAntibody-mediated Rejection Medical University of Vienna 4